Mide karsinomu seyrinde eozinofili: Olgu sunumu

Eozinofili, periferik kanda eozinofil sayısının 700/mm3 'den fazla olmasına denir. Eozinofilinin birçok nedeni vardır, en sık iki nedeni ise paraziter enfeksiyonlar ve allerjik hastalıklardır. Eozinofili, hematolojik malignitelerde, özellikle Hodgkin hastalığı, mikozis fungoidesde sık olarak görülmektedir; solid tümörlerde ise enderdir. Bu yazıda mide karsinomu ve kemoterapi sonrası dramatik olarak kaybolan eozinofili beraberliği gösteren bir olgu sunulmaktadır.

Abstract

Eosinophilia is defined as the amount of eosinophils more than 700/mm3 at the peripheral blood. There are many causes of eosinophilia, but the two most common ones are the parasitic infections and allergic disorders. Eosinophilia can be seen in hematological malignancies such as Hodgkin's disease and mycosis fungoides, and occured rarely in solid organ malignancies. In this article, we present a case with gastric carsinoma associated with eosinophilia that disappeared dramatically after chemotherapy.

🔖

Bu Makaleye Atıf Yap

ŞANLI, U. A., KARABULUT, B., TEKİN, F., SEZGİN, V. C., MÜEZZİNOĞLU, G. G., USLU, F. R., GÖKER, E., SAYDAM, G., ŞAHİN, F. (2022). Mide karsinomu seyrinde eozinofili: Olgu sunumu. Türk Hematoloji Onkoloji Dergisi, Cilt: 12 - Sayı: 4, 206–209. https://ajindex.com/articles/624760

📄 Tam Metin PDF Okuyucu

Yeni Sekmede Aç ↗

↗Yeni Sekme

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

Gleich GJ, Adolphson CR. The eosinophilic leukocyte: Structure and function. Adv Immunol 39:177-253, 1986
Narayanan G, Hussain BM, Chandralekha B, et al. Hypereosinophilie syndrome in acute lymphoblastic leukemia-case report and literature review. Acta Oncol 39(2):241-243, 2000
Teruya-Feldstein J, Tosato G, Jaffe ES. The role of chemokiries in Hodgkin's disease. Leuk Lymphoma 38(3-4):363-371, 2000
Samoszuk M. Eosinophils and human cancer. Histol Histopathol 12(3):807-812,1997
Lopez AF, Sanderson CJ, Gamble JR., et al. Recombinant human interleukin 5 is a selective activator of human eosinophil function. J Exp Med 167:219224, 1988
Yamaguchi Y, Suda T, Suda J, et al. Purified interleukin 5 support the terminal differentiation and proliferation of murine eosinophil precursors. J Exp Med 167:43-56, 1988
Teo CG, Singh M, Ting WC, et al. Evaluation of the common conditions associated with eosinophilia. J Clin Pathol 38:305-308, 1985
Sezer O, Schmid P, Hallek M, et al.Case report: Eosinophilia during fludarabine treatment of chronic lymphocytic leukemia. Ann Hematology 78(10):475-477, 1999
Isaacson NH, Rapoport P: Eosinophilia in malignant tumors: Its significance. Ann Intern Med 25:893, 1946
Slungaard A, Ascensao J, Zanjani E, et al. Pulmonary carcinoma with eosinophilia: Demonstration of a tumor-derived eosinophilopoietic factor. N Engl J Med 309:778-781, 1983
Hong SW, Cho MY, Park C. Expression of eosinophil chemotactic factors in stomach cancer. Yonsei Med J 40(2): 131 -136,1999
Grigolato PG, Favret M, Benetti A, et al.A case of gastric carcinoma with massive eosinophilia and squamous differentiation. Histochemical, immunohistochemical and ultrastructural aspects. Arch Anat Cytol Pathol 38(l-2):43-47, 1990
Obeso Fernandez G, Cabanillas Martin JJ, Lianes Barragen P, et al. Paraneoplastic blood hypereosinophilia in gastric carcinoma. Rev Esp Enferm Apar Dig 72(5):645(abs).